PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 2026Healthcare0 citationsOpen Access

Optimizing Opioid Use in Pain Management: A Comprehensive Review of Clinical Benefits, Risks, and Dependence

FCFrancisco Josué Cordero-PérezMPManuel Jesús Pérez-BaenaNPNuria Pina-Ruviralta

Key Points

  • The review aims to synthesize current knowledge on opioid mechanisms and strategies for optimizing their use in pain management.
  • Narrative review of existing literature on opioids in pain management.
  • Evaluation of clinical indications and safety considerations for opioid use.
  • Discussion of contemporary strategies for reducing risks associated with opioid therapy.
  • Opioids are effective for acute postoperative and cancer-related pain.
  • Risks of dependence and addiction are reduced in monitored patients.
  • Multimodal approaches and non-pharmacological therapies can enhance patient outcomes.

Abstract

Effective pain management is central to anesthesia, critical care, and perioperative medicine, and opioids remain essential agents for moderate-to-severe pain despite ongoing concerns regarding their safety and misuse. This narrative review synthesizes the current knowledge on opioid mechanisms, clinical indications, safety considerations, and evolving strategies aimed at optimizing their use. Opioids exert their analgesic effects primarily through μ-, δ-, and κ-opioid receptors, which modulate central and peripheral nociceptive pathways. They maintain a well-established role in acute postoperative and cancer-related pain, whereas their use in chronic non-cancer pain remains controversial. Contemporary evidence suggests that physiological dependence and addiction are less frequent in appropriately selected and monitored patients, although the risk increases in the presence of psychological comorbidity, prior substance use, or adverse social determinants of health. Unequal access, prescribing variability, and persistent disparities further complicate global opioid management strategies. Recent advances, including partial agonists such as buprenorphine, dual-mechanism agents such as tapentadol, individualized titration, opioid rotation, and the integration of multimodal analgesia, support safer and more tailored prescribing. Non-pharmacological interventions, including behavioral and physical therapies, increasingly complement pharmacological strategies to minimize opioid exposure and improve functional outcomes. Clinicians must balance analgesic efficacy with adverse effects, such as tolerance, opioid-induced hyperalgesia, sedation, and respiratory depression, particularly in perioperative and critically ill populations. Opioids remain indispensable for selected indications but should be incorporated into a comprehensive, patient-centered, multimodal analgesic approach that prioritizes safety, ongoing reassessment, and individualized risk mitigation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cordero-Pérez et al. (2026) studied this question.

synapsesocial.com/papers/698d6edc5be6419ac0d54b6bhttps://doi.org/10.3390/healthcare14040457
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genetic Polymorphisms in the ABCB1 Gene and the Effects of Fentanyl in Koreans2006 · 120 citations
  2. 2Trends and characteristics of accidental and intentional codeine overdose deaths in Australia2015 · 67 citations
  3. 3Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication2006 · 442 citations
  4. 4EULAR revised recommendations for the management of fibromyalgia2016 · 1,549 citations
  5. 5Neuropathic cancer pain: prevalence, pathophysiology, and management2018 · 199 citations